Skip to main content
. 2021 Feb 25;13(5):952. doi: 10.3390/cancers13050952

Table 4.

Univariate and multivariate analysis of factors associated with poorer overall survival.

Univariate Multivariate
n HR 95% CI p HR 95% CI p
Age Cohort 65–69 91 - - - - - -
70–74 79 1.40 (0.96–2.05) 0.081 0.95 (0.60–1.52) 0.833
75–79 53 1.07 (0.68–1.68) 0.772 0.79 (0.44–1.43) 0.441
>80 57 2.20 (1.47–3.27) 0.000 1.76 (1.03–3.02) 0.04
FIGO Stage 1 37 - - -
2 28 1.30 (0.55–3.07) 0.553 7.91 (0.98–63.61) 0.052
3 158 3.69 (1.98–6.89) 0.000 12.99 (1.77–95.20) 0.012
4 55 6.00 (3.08–11.68) 0.000 16.16 (2.11–123.61) 0.007
ECOG PS 0 56 - - -
1 122 1.86 (1.18–2.93) 0.007 2.14 (1.21–3.79) 0.009
2 55 4.02 (2.47–6.53) 0.000 2.53 (1.20–5.35) 0.015
3 26 7.36 (4.13–13.13) 0.000 3.51 (1.37–8.99) 0.009
Cardiovascular disease 77 1.38 (1.01–1.90) 0.043 0.99 (0.62–1.57) 0.95
Taking 3 or more medications 111 0.07 (0.01–0.55) 0.011 1.12 (0.72–1.74) 0.62
Osteoarthritis 16 1.70 (0.96–3.01) 0.070 1.62 (0.76–3.44) 0.209
Reduced activities of daily living 70 2.89 (2.10–3.98) 0.000 1.53 (0.90–2.62) 0.118
History of depression 11 1.86 (0.95–3.65) 0.071 1.89 (0.83–4.30) 0.128
History of weight loss 66 1.51 (1.09–2.11) 0.015 0.93 (0.59–1.47) 0.754
Albumin <35 g/L 114 2.09 (1.56–2.81) 0.000 1.52 (0.97–2.38) 0.065
Haemoglobin <120 g/L 141 1.28 (0.9601.72) 0.093 0.80 (0.53–1.23) 0.311
GFR <60 mL/min 104 1.33 (0.98–1.79) 0.064 1.11 (0.74–1.68) 0.607